Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APATURA: Inhaled AZD1402 for Asthma
NCT04643158Phase 2Terminated
- Sponsor
- AstraZeneca
- Start
- Mar 2021
- Primary completion
- Jul 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 10
01
Overview
A Phase 2 trial of elarekibep in asthma, sponsored by AstraZeneca. Started Mar 2021; status: terminated.
02
Drugs
elarekibep
03
Conditions
asthma
Beyond the preview
Go deeper on NCT04643158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04643158.